Drug Profile
Anti-TNF sheep monoclonal antibody - KS Biomedix Holdings
Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator KS Biomedix Holdings
- Class Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Crohn's disease; Septic shock
Most Recent Events
- 27 Sep 2002 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
- 27 Sep 2002 Discontinued - Preclinical for Crohn's disease in United Kingdom (unspecified route)
- 27 Sep 2002 Discontinued - Preclinical for Septic shock in United Kingdom (unspecified route)